Hepatic hemangioendothelioma of infancy: clinical features of a large cohort of patients and proposed management

Retrospective study of 27 infants with symptomatic hepatic hemangioendothelioma found 85% survival with multimodal treatment including medical therapy, embolization, and surgery. Poor prognostic factors included diffuse lesions, cardiac failure, type II histology, and presentation after 6 months of age.